Report overview
The global Chromosomal Microarray (CMA) Familial Testing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Single Nucleotide Polymorphism (SNP) Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Chromosomal Microarray (CMA) Familial Testing include Baylor Genetics, MedGenome Labs, Centogene, GeneDx, Quest Diagnostics, LabCorp, Lineagen, Invitae and Illumina Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Chromosomal Microarray (CMA) Familial Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chromosomal Microarray (CMA) Familial Testing. This report contains market size and forecasts of Chromosomal Microarray (CMA) Familial Testing in global, including the following market information:
Global Chromosomal Microarray (CMA) Familial Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Chromosomal Microarray (CMA) Familial Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chromosomal Microarray (CMA) Familial Testing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Chromosomal Microarray (CMA) Familial Testing Market Segment Percentages, by Type, 2023 (%)
Single Nucleotide Polymorphism (SNP)
Comparative Genomic Hybridization (CGH)
Global Chromosomal Microarray (CMA) Familial Testing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Chromosomal Microarray (CMA) Familial Testing Market Segment Percentages, by Application, 2023 (%)
Medical
Laboratory
Clinical
Others
Global Chromosomal Microarray (CMA) Familial Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Chromosomal Microarray (CMA) Familial Testing Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chromosomal Microarray (CMA) Familial Testing revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Chromosomal Microarray (CMA) Familial Testing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baylor Genetics
MedGenome Labs
Centogene
GeneDx
Quest Diagnostics
LabCorp
Lineagen
Invitae
Illumina Inc.
CD Genomics
Thermo Fisher
Agilent
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chromosomal Microarray (CMA) Familial Testing, market overview.
Chapter 2: Global Chromosomal Microarray (CMA) Familial Testing market size in revenue.
Chapter 3: Detailed analysis of Chromosomal Microarray (CMA) Familial Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chromosomal Microarray (CMA) Familial Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
